AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Nuwellis to Report Q2 2025 Financial Results on August 12, 2025
ByAinvest
Sunday, Jul 27, 2025 10:56 am ET1min read
Nuwellis, Inc. will announce its Q2 2025 financial results on August 12, 2025, and host a conference call and webcast at 9:00 AM ET on the same day. Investors can access the live webcast on the company's investor relations website or by dialing the provided numbers with conference ID: NUWEQ2. Nuwellis is a medical technology company specializing in fluid overload treatments and commercializing the Aquadex SmartFlow system.
Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company, has scheduled the release of its second quarter 2025 financial results for August 12, 2025. The company will host a conference call and webcast at 9:00 AM ET to discuss the results and provide a general business update.Investors can access the live webcast through the company's investor relations website at [ir.nuwellis.com](https://ir.nuwellis.com), or join the conference call by dialing 1-800-245-3047 (U.S.) or 1-203-518-9765 (international) using the conference ID: NUWEQ2. An audio archive of the webcast will be available following the call on the Investors page at [ir.nuwellis.com](https://ir.nuwellis.com).
Nuwellis is focused on transforming the lives of patients suffering from fluid overload through its science, collaboration, and innovation. The company specializes in commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible, and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). It is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics.
For more information about Nuwellis and the Aquadex SmartFlow system, visit [ir.nuwellis.com](https://ir.nuwellis.com) or follow the company on LinkedIn or X.
References:
[1] https://www.globenewswire.com/news-release/2025/07/22/3119398/0/en/Nuwellis-Inc-To-Report-Second-Quarter-2025-Financial-Results-on-August-12-2025.html
[2] https://www.stocktitan.net/news/NUWE/nuwellis-inc-to-report-second-quarter-2025-financial-results-on-0pqrpzck6zw5.html
[3] https://www.nasdaq.com/press-release/nuwellis-inc-report-second-quarter-2025-financial-results-august-12-2025-2025-07-22
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet